4 months Syndax Pharmaceuticals (SNDX) Reports Q3 Loss, Tops Revenue Estimates Zacks

   X     

4 months Vertex Pharmaceuticals: Strong Execution Continued In Q3 But The Valuation Reflects It Seeking Alpha

   X     

4 months Apellis Pharmaceuticals, Inc. 2024 Q3 – Results – Earnings Call Presentation Seeking Alpha

   X     

4 months Apellis Pharmaceuticals, Inc. (APLS) Q3 2024 Earnings Call Transcript Seeking Alpha

   X     

4 months Earnings call: Supernus Pharmaceuticals reported a significant increase in total revenue Investing.com

   X     

4 months PFE or NVO: Which Is the Better Value Stock Right Now? Zacks

   X     

4 months VRTX Q3 Earnings & Sales Trump Estimates, ’24 Sales View Raised Zacks

   X     

4 months What the vote means for corporate America Financial Times

   X     

4 months Supernus Pharmaceuticals, Inc. (SUPN) Q3 2024 Earnings Call Transcript Seeking Alpha

   X     

4 months Vertex Pharmaceuticals Incorporated 2024 Q3 – Results – Earnings Call Presentation Seeking Alpha

   X     

4 months Vertex Pharmaceuticals Incorporated (VRTX) Q3 2024 Earnings Call Transcript Seeking Alpha

   X     

4 months Supernus (SUPN) Reports Q3 Earnings: What Key Metrics Have to Say Zacks

   X     

4 months Supernus Pharmaceuticals (SUPN) Beats Q3 Earnings and Revenue Estimates Zacks

   X     

4 months BioCryst Pharmaceuticals, Inc. 2024 Q3 – Results – Earnings Call Presentation Seeking Alpha

   X     

4 months BioCryst Pharmaceuticals (BCRX) Reports Q3 Loss, Tops Revenue Estimates Zacks

   X     

4 months Rezdiffra Gains Traction In NASH As Madrigal Pharmaceuticals Targets European Expansion Seeking Alpha

   X     

4 months ANI Pharmaceuticals Is Acting Like It Is Being Acquired Seeking Alpha

   X     

4 months Recursion Pharmaceuticals (RXRX) Exceeds Market Returns: Some Facts to Consider Zacks

   X     

4 months Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target Raised to $441.00 at UBS Group MarketBeat

   X     

4 months Tarsus Pharmaceuticals (NASDAQ:TARS) Trading Up 8.5% – What’s Next? MarketBeat

   X     

4 months Healthcare Investing Finding Growth Beyond Pharmaceuticals Seeking Alpha

   X     

4 months Longboard Pharmaceuticals (NASDAQ:LBPH) Reaches New 1-Year High – Here’s What Happened MarketBeat

   X     

4 months Scotiabank Forecasts Strong Price Appreciation for Agios Pharmaceuticals (NASDAQ:AGIO) Stock MarketBeat

   X     

4 months Earnings Preview: ANI Pharmaceuticals (ANIP) Q3 Earnings Expected to Decline Zacks

   X     

4 months Earnings Preview: Amneal Pharmaceuticals (AMRX) Q3 Earnings Expected to Decline Zacks

   X     

4 months Madrigal Q3 Earnings Beat, NASH Drug Sales Drive Top Line, Stock Up Zacks

   X     

4 months Alnylam Q3 Loss In Line With Estimates, Revenues Miss, Stock Down Zacks

   X     

4 months Fennec Pharmaceuticals (FRX) Scheduled to Post Quarterly Earnings on Thursday MarketBeat

   X     

4 months Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says MarketBeat

   X     

4 months Amneal Pharmaceuticals (AMRX) Scheduled to Post Quarterly Earnings on Friday MarketBeat

   X     

4 months Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Given Consensus Recommendation of “Moderate Buy” by Analysts MarketBeat

   X     

4 months Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? Zacks

   X     

4 months Kiniksa Pharmaceuticals (NASDAQ:KNSA) Price Target Raised to $35.00 MarketBeat

   X     

4 months Jazz Pharmaceuticals (JAZZ) Earnings Expected to Grow: Should You Buy? Zacks

   X     

4 months Ionis Pharmaceuticals (IONS) Expected to Beat Earnings Estimates: Can the Stock Move Higher? Zacks

   X     

4 months Avadel Pharmaceuticals plc (NASDAQ:AVDL) Short Interest Update MarketBeat

   X     

4 months AMI Asset Management Corp Purchases Shares of 51,262 Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) MarketBeat

   X     

4 months DekaBank Deutsche Girozentrale Acquires 31,283 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) MarketBeat

   X     

4 months Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Given Average Rating of “Moderate Buy” by Analysts MarketBeat

   X     

4 months Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives Average Recommendation of “Buy” from Analysts MarketBeat

   X     

4 months Lexicon Pharmaceuticals (NASDAQ:LXRX) Shares Up 9.7% – Here’s Why MarketBeat

   X     

4 months Tarsus Pharmaceuticals (NASDAQ:TARS) Hits New 12-Month High – What’s Next? MarketBeat

   X     

4 months EyePoint Pharmaceuticals (NASDAQ:EYPT) Trading Down 6.5% – Should You Sell? MarketBeat

   X     

4 months Kiniksa Pharmaceuticals (NASDAQ:KNSA) Shares Gap Down – Should You Sell? MarketBeat

   X     

4 months Recursion Pharmaceuticals (NASDAQ:RXRX) Trading Down 1.6% Following Insider Selling MarketBeat

   X     

4 months Vertex Gears Up to Report Q3 Earnings: Is a Beat in the Cards? Zacks

   X     

4 months Semanteon Capital Management LP Buys Shares of 22,057 Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) MarketBeat

   X     

4 months EyePoint Pharmaceuticals (EYPT) Soars 27.6%: Is Further Upside Left in the Stock? Zacks

   X     

4 months Zacks.com featured highlights include Vertiv, Limbach, Atour Lifestyle and Catalyst Pharmaceuticals Zacks

   X     

4 months Vertex Pharmaceuticals (VRTX) Stock Drops Despite Market Gains: Important Facts to Note Zacks

   X